Skip to content

LivaNova LIVN Derivative Liabilities - Fair Value

Derivative Liabilities - Fair Value at other companies

ICU Medical logo
ICU MedicalICUI
$4.91M+13.3%
Abbott logo
AbbottABT
Medtronic logo
MedtronicMDT
ResMed logo
ResMedRMD
Boston Scientific logo
Boston ScientificBSX
Baxter International logo
Baxter InternationalBAX

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:DerivativeLiabilitiesCurrent.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's derivative liabilities - fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's derivative liabilities - fair value?
LivaNova (LIVN) reported derivative liabilities - fair value of $613K in Q1 2026.
How has LivaNova's derivative liabilities - fair value changed year-over-year?
LivaNova's derivative liabilities - fair value decreased by 31.4% year-over-year, from $893K to $613K.
What is the long-term trend for LivaNova's derivative liabilities - fair value?
Over 5 years (2020 to 2025), LivaNova's derivative liabilities - fair value has grown at a -57.8% compound annual growth rate (CAGR), from $7.37M to $99K.
What does derivative liabilities - fair value mean?
This metric represents the total fair market value of all derivative contracts currently in a liability position for the institution. It reflects the potential cash outflow required if these contracts were settled at the current reporting date. Monitoring this value is essential for assessing the bank's exposure to market volatility and counterparty risk.